BioSpace News Archive

Policy

U.S. FDA Grants Priority Review for Genmab’s Daratumumab in Front Line Multiple Myeloma

The sBLA was submitted by Genmab’s licensing partner, Janssen Biotech, Inc., in November 2017.

January 22, 2018
·
10 min read
Drug Development

Kineta Immuno-Oncology Announces Presentation on Novel RIG-I Agonists at Immuno-Oncology Frontiers World Conference

The conference takes place on January 22-25 at the Hyatt Regency Hotel in Miami, FL.

January 22, 2018
·
3 min read
BioMidwest

OmegaFlex Introduces World’s First Corrugated Medical Gas Tubing for Healthcare Use

OmegaFlex has announced MediTrac as the world’s first corrugated medical tubing for distribution of medical gases.

January 22, 2018
·
2 min read
Business

ResMed Announces Results for the Second Quarter of Fiscal Year 2018

ResMed today announced results for its quarter ended December 31, 2017.

January 22, 2018
·
29 min read
Pharm Country

BD Board Declares Dividend

The indicated annual dividend rate is $3.00 per share.

January 22, 2018
·
1 min read
Business

SillaJen and ABL Europe Expand Strategic Manufacturing Collaboration for Oncolytic Virus Therapies

Under the current agreement, ABL is currently manufacturing Pexa-Vec for SillaJen’s multinational, randomized Phase 3, open-label study of Pexa-Vec in patients with advanced liver cancer.

January 22, 2018
·
4 min read
FDA

Medrobotics Wins FDA Nod for World’s First and Only Flexible Transabdominal and Transthoracic Robotic Scope

This clearance reaffirms the Company’s progress to develop transformative products for single-port general, gynecological, thoracic and urological surgeries.

January 22, 2018
·
2 min read
Business

IONTAS to Generate Antibodies using Mammalian Display Technology for a Global Biopharma

IONTAS Limited, a leader in the discovery and optimisation of fully human antibodies, announced today that it has signed an agreement with Sanofi to discover antibodies using IONTAS’ proprietary Mammalian Display Technology.

January 22, 2018
·
2 min read
Business

David Harding to Join TransMed7, LLC Business Advisory Board

Mr. David Harding is currently the Senior Vice-President (SVP) of Corporate Strategy and Business Development at Exact Sciences, a diagnostics company focused on colorectal cancer screening.

January 22, 2018
·
4 min read
Policy

Regeneron Announces Approval of DUPIXENT (dupilumab) in Japan for the Treatment of Atopic Dermatitis

Regeneron today announced that the MHLW in Japan has granted marketing and manufacturing authorization for DUPIXENT for the treatment of atopic dermatitis in adults not adequately controlled with existing therapies.

January 22, 2018
·
9 min read